Literature DB >> 32592669

Cabotegravir, a new option for PrEP.

Tony Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32592669     DOI： 10.1016/S1473-3099(20)30497-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  Barriers to Pre-Exposure Prophylaxis Uptake Among Online Male Sex Workers in the US.

Authors:  Anne E Sundelson; Étienne Meunier; Eric W Schrimshaw; Karolynn Siegel
Journal:  AIDS Behav       Date:  2021-10-27

2.  Design and Testing of a Cabotegravir Implant for HIV Prevention.

Authors:  Dipu Karunakaran; Solange M Simpson; Jonathan T Su; Ewa Bryndza-Tfaily; Thomas J Hope; Ronald Veazey; Georgina Dobek; Jiang Qiu; David Watrous; Samuel Sung; Jorge E Chacon; Patrick F Kiser
Journal:  J Control Release       Date:  2020-12-19       Impact factor: 9.776

Review 3.  Injectable Antiretroviral Drugs: Back to the Future.

Authors:  Marco Berruti; Niccolò Riccardi; Diana Canetti; Sergio Lo Caputo; Lucia Taramasso; Antonio Di Biagio
Journal:  Viruses       Date:  2021-02-02       Impact factor: 5.048

Review 4.  Development of New Strategies for Malaria Chemoprophylaxis: From Monoclonal Antibodies to Long-Acting Injectable Drugs.

Authors:  Joerg J Moehrle
Journal:  Trop Med Infect Dis       Date:  2022-04-07

Review 5.  Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men.

Authors:  Errol L Fields; Sophia A Hussen; David J Malebranche
Journal:  Curr HIV/AIDS Rep       Date:  2020-12       Impact factor: 5.071
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.